Brexucabtagene autoleucel (Intravenous)
Medically reviewed by Drugs.com. Last updated on Mar 6, 2022.
Warning: Cytokine Release Syndrome and Neurologic ToxicitiesCytokine Release Syndrome (CRS), including life-threatening reactions, occurred in patients receiving brexucabtagene autoleucel. Do not administer brexucabtagene autoleucel to patients with active infection or inflammatory disorders. Treat severe or life-threatening CRS with tocilizumab or tocilizumab and corticosteroids.Neurologic toxicities, including life-threatening reactions, occurred in patients receiving brexucabtagene autoleucel, including concurrently with CRS or after CRS resolution. Monitor for neurologic toxicities after treatment with brexucabtagene autoleucel. Provide supportive care and/or corticosteroids, as needed.Brexucabtagene autoleucel is only available through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the Yescarta(TM) and Tectartus(TM) REMS Program .
Commonly used brand name(s)
In the U.S.
Available Dosage Forms:
Therapeutic Class: Immunological Agent
Uses for brexucabtagene autoleucel
Brexucabtagene autoleucel injection is used to treat mantle cell lymphoma (MCL) and acute lymphoblastic leukemia (ALL) in patients who have received other cancer medicines but did not work well.
Brexucabtagene autoleucel is an antineoplastic (cancer) medicine that is made from your own white blood cells, which have been modified to recognize and attack your cancer cells. Before you begin treatment, talk to your doctor about the benefits of brexucabtagene autoleucel as well as the possible risks of receiving it.
Brexucabtagene autoleucel is available only under a restricted distribution program called the Yescarta™ and Tecartus™ REMS (Risk Evaluation and Mitigation Strategy) Program.
Before using brexucabtagene autoleucel
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For brexucabtagene autoleucel, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to brexucabtagene autoleucel or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of brexucabtagene autoleucel injection in the pediatric population. Safety and efficacy have not been established.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of brexucagtagene autoleucel injection in the elderly.
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with medicines
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving brexucabtagene autoleucel, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using brexucabtagene autoleucel with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
- Adenovirus Vaccine
- Bacillus of Calmette and Guerin Vaccine, Live
- Cholera Vaccine, Live
- Dengue Tetravalent Vaccine, Live
- Influenza Virus Vaccine, Live
- Measles Virus Vaccine, Live
- Mumps Virus Vaccine, Live
- Poliovirus Vaccine, Live
- Rotavirus Vaccine, Live
- Rubella Virus Vaccine, Live
- Smallpox Vaccine
- Typhoid Vaccine, Live
- Varicella Virus Vaccine, Live
- Yellow Fever Vaccine
- Zoster Vaccine, Live
Interactions with food/tobacco/alcohol
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
Other medical problems
The presence of other medical problems may affect the use of brexucabtagene autoleucel. Make sure you tell your doctor if you have any other medical problems, especially:
- Heart problems or
- Infections (including hepatitis B), active or history of or
- Lung or breathing problems or
- Seizures, history of or
- Stroke, history of—Use with caution. May cause side effects to become worse.
- Kidney disease or
- Liver disease—Brexucabtagene autoleucel has not been studied in patients with these conditions.
Proper use of brexucabtagene autoleucel
A nurse or other trained health professional will give you brexucabtagene autoleucel in a medical facility. It is given through a needle placed into one of your veins using a pump. The medicine must be injected slowly, so your IV tube will need to stay in place for less than 30 minutes. It is given 3 days after completing treatment with other cancer medicines (eg, fludarabine, cyclophosphamide).
Your doctor will check you for unwanted effects at least daily for 7 days. Your doctor may also want you to stay close to the hospital or center for at least 4 weeks after your infusion.
It is very important that you understand the requirements of the Yescarta™ and Tecartus™ REMS program, and become familiar with the Tecartus™ medication guide. Read and follow these instructions carefully. Ask your doctor if you have any questions. Ask your pharmacist for the medication guide if you do not have one.
You may be given other medicines (eg, allergy medicine, fever medicine) 1 hour before starting treatment with brexucabtagene autoleucel.
Precautions while using brexucabtagene autoleucel
It is very important that your doctor check your progress at regular visits to make sure that brexucabtagene autoleucel is working properly. Blood tests are needed to check for unwanted effects.
Using brexucabtagene autoleucel while you are pregnant can harm your unborn baby. If you are a woman who can bear children, your doctor may give you a pregnancy test before you start using brexucabtagene autoleucel to make sure you are not pregnant. Tell your doctor right away if pregnancy occurs while you are using brexucabtagene autoleucel.
Brexucabtagene autoleucel may cause cytokine release syndrome (CRS). This may be life-threatening and requires immediate attention. Tell your doctor right away if you have fever, chills, headache, nausea, lightheadedness, dizziness, fainting, skin rash, trouble breathing, or tiredness or weakness.
Check with your doctor right away if you have seizures, loss of balance, loss of consciousness, confusion, disorientation, difficulty with speaking, or slurred speech. These could be symptoms of a serious nerve problem.
Brexucabtagene autoleucel may cause a severe inflammatory condition that could be life-threatening, including hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), which is caused by an overactive immune system. Check with your doctor right away if you have a fever, cough that does not go away, right upper abdominal or stomach pain and fullness, rash, redness in one part of your body, swollen, painful, or tender lymph glands in the neck, armpit, or groin, mental status changes, shakiness and unsteady walk, unsteadiness, trembling, or other problems with muscle control or coordination, seizures, or warm feeling or swelling of your skin.
Brexucabtagene autoleucel may cause serious allergic reactions, including anaphylaxis, which can be life-threatening and require immediate medical attention. Check with your doctor right away if you have a rash, itching, dizziness, fainting, fast heartbeat, trouble breathing or swallowing, or chest tightness while you are using brexucabtagene autoleucel.
Brexucabtagene autoleucel can temporarily lower the number of white blood cells in your blood, which increases the chance of getting an infection. If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you have a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.
Brexucabtagene autoleucel may increase your risks for hypogammaglobulinemia (immune system problem) and getting other cancers. Talk to your doctor if you have questions about these risks.
Brexucabtagene autoleucel may cause dizziness, confusion, seizures, or decreased alertness. Do not drive or do anything else that could be dangerous until you know how brexucabtagene autoleucel affects you, for at least 8 weeks after treatment.
While you are being treated with brexucabtagene autoleucel injection, do not have any immunizations (vaccinations) without your doctor's approval. Live virus vaccinations should not be given for at least 6 weeks before start of treatment, during treatment, and until recovery following the last cycle of brexucabtagene autoleucel.
Brexucabtagene autoleucel side effects
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur:
- back pain
- bloody urine
- blurred vision
- chest pain or tightness
- confusion as to time, place, or person
- decreased frequency in urinating
- difficulty swallowing
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- dry mouth
- fast, pounding, or irregular heartbeat or pulse
- holding false beliefs that cannot be changed by fact
- increased thirst
- loss of appetite
- lower back or side pain
- mood or mental changes
- muscle or bone pain
- muscle spasm or twitching
- nausea and vomiting
- problems with speech or speaking
- stiff neck
- stomach pain
- swelling of the face, fingers, feet, or lower legs
- tenderness, pain, swelling, warmth, skin discoloration, and prominent superficial veins at the injection site
- trouble breathing
- unusual excitement, nervousness, or restlessness
- unusual tiredness or weakness
- weight gain
- Blue lips and fingernails
- difficult, fast, noisy breathing
- pale skin
- unsteadiness, trembling, or other problems with muscle control or coordination
Incidence not known
- Dark urine
- hives, itching, skin rash
- light-colored stools
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- upper right stomach pain
- yellow eyes and skin
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
- trouble sleeping
- Darkening of the skin
- dry skin
- increased sweating
- loss or thinning of the hair
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
More about brexucabtagene autoleucel
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- En español
- Drug class: miscellaneous antineoplastics
- Other brands
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.